Adam David Bezinque

Adam Bezinque practices at Corewell Health Grand Rapids Hospitals - Butterworth in Grand Rapids, Michigan, part of Corewell Health.

Adam Bezinque's NPI, 1487158531, was assigned on March 22, 2018. Adam Bezinque graduated from Michigan State University College of Osteopathic Medicine in 2018. Adam Bezinque holds Michigan license 5101027421.

Adam Bezinque's primary practice is Corewell Health Grand Rapids Hospitals - Butterworth, at 100 Michigan St NE, Grand Rapids, MI 49503 in Kent County. The practice phone is (616) 391-1774.

Adam Bezinque's primary practice is Corewell Health Grand Rapids Hospitals - Butterworth in Grand Rapids, Michigan, part of Corewell Health. Adam Bezinque is also affiliated with Trinity Health Grand Rapids Hospital. The medical group on file is Corewell Health Medical Group West. Dmand AI also links Adam Bezinque to 3 more hospitals, 4 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Adam Bezinque practices, 8 sites in all. Vendor and product names are available with a free account.

Urology is Adam Bezinque's primary specialty in the NPI Registry, under taxonomy code 208800000X. Adam Bezinque is licensed in Michigan.

CMS data shows 246 Medicare services from Adam Bezinque across 9 procedure codes in 2024, for 150 Medicare patients. Medicare paid $14,919 for them.

CMS counts 150 Medicare patients who saw Adam Bezinque in 2024. The largest group is 65 to 74, with 58 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Adam Bezinque's median patient age at 67, with 26% women.

In 2024, Adam Bezinque wrote 763 Medicare Part D claims for 277 patients. 88% of them were for generic drugs. CMS names the drug for 651 of them, across 14 drugs with 11 or more claims each, at $64,497 in total drug cost. In 2023, CMS named 316 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Adam Bezinque for performance year 2024, reported as part of a group. Adam Bezinque accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Adam Bezinque as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Adam Bezinque, published from 2016 to 2021. 2018 was the busiest year, with 2. The most frequent topics are Kidney Neoplasms, Nephrectomy and Renal Insufficiency, Chronic. Adam Bezinque's most frequent co-authors are Crystal Rene Norgren Farrell, MD, Murali K. Ankem, MD and Bradford W. Betz, MD.

CMS Open Payments shows 66 general payments to Adam Bezinque from 32 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $257.

Adam Bezinque graduated from Michigan State University College of Osteopathic Medicine in 2018.